Smoking influence in Takotsubo syndrome: insights from an international cohort

dc.contributor.authorNúñez Gil, Iván Javier
dc.contributor.authorSantoro, Francesco
dc.contributor.authorVazirani, Ravi
dc.contributor.authorNovo, Giuseppina
dc.contributor.authorBlanco Ponce, Emilia
dc.contributor.authorArcari, Luca
dc.contributor.authorUribarri, Aitor
dc.contributor.authorCacciotti, Luca
dc.contributor.authorGuerra, Federico
dc.contributor.authorStiermaier, Thomas
dc.contributor.authorEt al.
dc.date.accessioned2024-02-03T15:43:04Z
dc.date.available2024-02-03T15:43:04Z
dc.date.issued2023
dc.description.abstractAims: To assess the influence of tobacco on acute and long-term outcomes in Takotsubo syndrome (TTS).Methods: Patients with TTS from the international multicenter German Italian Spanish Takotsubo registry (GEIST) were analyzed. Comparisons between groups were performed within the overall cohort, and an adjusted analysis with 1:1 propensity score matching was conducted.Results: Out of 3,152 patients with TTS, 534 (17%) were current smokers. Smoker TTS patients were younger (63 +/- 11 vs. 72 +/- 11 years, p < 0.001), less frequently women (78% vs. 90%, p < 0.001), and had a lower prevalence of hypertension (59% vs. 69%, p < 0.01) and diabetes mellitus (16% vs. 20%, p = 0.04), but had a higher prevalence of pulmonary (21% vs. 15%, p < 0.01) and/or psychiatric diseases (17% vs. 12%, p < 0.01). On multivariable analysis, age less than 65 years [OR 3.85, 95% CI (2.86-5)], male gender [OR 2.52, 95% CI (1.75-3.64)], history of pulmonary disease [OR 2.56, 95% CI (1.81-3.61)], coronary artery disease [OR 2.35, 95% CI (1.60-3.46)], and non-apical ballooning form [OR 1.47, 95% CI (1.02-2.13)] were associated with smoking status. Propensity score matching (PSM) 1:1 yielded 329 patients from each group. Smokers had a similar rate of in-hospital complications but longer in-hospital stays (10 vs. 9 days, p = 0.01). During long-term follow-up, there were no differences in mortality rates between smokers and non-smokers (5.6% vs. 6.9% yearly in the overall, p = 0.02, and 6.6%, vs. 7.2% yearly in the matched cohort, p = 0.97).Conclusions: Our findings suggest that smoking may influence the clinical presentation and course of TTS with longer in-hospital stays, but does not independently impact mortality.spa
dc.description.filiationUEMspa
dc.description.impact2.8 Q2 JCR 2023spa
dc.description.impact0.863 Q2 SJR 2023spa
dc.description.impactNo data IDR 2023spa
dc.description.sponsorshipFundación Interhospitalaria para la Investigación en Cardiologíaspa
dc.identifier.citationNúñez-Gil, I. J., Santoro, F., Vazirani, R., Novo, G., Blanco-Ponce, E., Arcari, L., Uribarri, A., Cacciotti, L., Guerra, F., Salamanca, J., Musumeci, B., Vedia, O., Mariano, E., Fernández-Cordón, C., Caldarola, P., Montisci, R., Brunetti, N. D., El-Battrawy, I., Abumayyaleh, M., … Stiermaier, T. (2023). Smoking influence in Takotsubo syndrome: Insights from an international cohort. Frontiers in Cardiovascular Medicine, 10, 1282018. https://doi.org/10.3389/fcvm.2023.1282018spa
dc.identifier.doi10.3389/fcvm.2023.1282018
dc.identifier.issn2297-055X
dc.identifier.urihttp://hdl.handle.net/11268/12645
dc.language.isoengspa
dc.peerreviewedSispa
dc.relation.publisherversionhttps://doi.org/10.3389/fcvm.2023.1282018spa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.accessRightsopen accessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.otherCardiomiopatía de Takotsubospa
dc.subject.otherFumarspa
dc.subject.unescoSistema cardiovascularspa
dc.subject.unescoMortalidadspa
dc.titleSmoking influence in Takotsubo syndrome: insights from an international cohortspa
dc.typejournal articlespa
dspace.entity.typePublication
relation.isAuthorOfPublicatione2ca7752-c935-4769-85e5-5eb5944e3178
relation.isAuthorOfPublication.latestForDiscoverye2ca7752-c935-4769-85e5-5eb5944e3178

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Nuñez_Gil_Ivan3_2023.pdf
Size:
1.32 MB
Format:
Adobe Portable Document Format
Description: